Albert Labs International Corp.
Albert Labs International Corp. is a research and drug development company addressing mental health care needs. Through a succinct clinical pathway, focusing on Real World Evidence (RWE) Albert Labs look to commercialize its psychedelic-based treatments, and in doing so deliver psychedelic-assisted psychotherapy to patients sooner. Focused on accelerating access and faster approvals, Albert Labs put patients with urgent and unmet needs first as it develops licensed medicines to treat a variety of mental health conditions. Cancer-related distress, an initial focus of Albert Labs development program is thought to affect over 16 million patients worldwide.
Albert Labs International Corp. (ABRT)
le 9 mars/March 2022
The common shares of Albert Labs International Corp., previously listed as ME Resource Corp., (MEC) have been approved for listing on the CSE.
Listing and disclosure documents will be available at www.thecse.com on the trading date.